Concepedia

Xingdi Ma

XM

Statistics

Publications

7

Citations

1K

H-Index

7

Active since

2019

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Nanfang Hospital

Southern Medical University

Broad Institute

Brown Foundation

Xingdi Ma is an author at The University of Texas MD Anderson Cancer Center specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2019–2024

7

Publications

7

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text

, , +16

Tumor Microenvironment Remodeling Enables Bypass of Oncogenic KRAS Dependency in Pancreatic Cancer

Pingping Hou, Avnish Kapoor, Qiang Zhang et al. · Cancer Discovery · 2020 · 152 citations · Full text

, , +17

USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation

Pingping Hou, Xingdi Ma, Qiang Zhang et al. · Genes & Development · 2019 · 97 citations · Full text

, , +16

Efficient gene knockout and genetic interaction screening using the in4mer CRISPR/Cas12a multiplex knockout platform

Nazanin Esmaeili Anvar, Chenchu Lin, Xingdi Ma et al. · Nature Communications · 2024 · 67 citations · Full text

, , +17

P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis

Ming Zhu, Ruiqing Peng, Xin Liang et al. · Oncogene · 2021 · 42 citations · Full text

, , +14

1–5 of 7